Anthony Jake Demetris
Affiliation: University of Pittsburgh
- Distinguishing between recurrent primary sclerosing cholangitis and chronic rejectionAnthony Jake Demetris
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
Liver Transpl 12:S68-72. 2006..5. Potential discriminating features include liver size and gross appearance, and histopathology findings in the arterial tree, hilar lymph nodes, large and small bile ducts, interface zone, lobular, and perivenular regions...
- The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cellsTong Wu
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Mol Cancer Ther 3:299-307. 2004..These findings suggest that celecoxib inhibits cholangiocarcinoma growth partly through induction of apoptosis and inhibition of Akt phosphorylation...